ADC |
Antibody–Drug Conjugate |
mAb |
Monoclonal Antibody |
HER |
Human Epidermal Growth Factor |
TZM |
Trastuzumab |
CAGR |
Compound Annual Growth Rate |
ADCC |
Antibody-Dependent Cell-Mediated Cytotoxicity |
CDC |
Complement-Dependent Cytotoxicity |
MRI |
Magnetic Resonance Imaging |
CT |
Computer Tomography |
ACNP |
Antibody-Conjugated Nanoparticle |
NPDC |
Nanoparticle–Drug Conjugate |
PDUFA |
Prescription Drug User Fee Act |
ROI |
Return of Investment |
NME |
New Molecular Entity |
M&A |
Mergers and Acquisitions |
PBF |
Project-Based Firm |
PNO |
Project Network Organization |